Key facts
- This page summarizes Ryan Nicholson's Form 4 filing for Dolby Laboratories, Inc. (DLB).
- 4 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 17 Aug 2021, 18:19.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Sale
Options Exercise
Sale
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Options Exercise
Additional SEC filing notes
Footnote F1
This transaction was executed in multiple trades at prices ranging from $101.023 to $101.045. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
Footnote F2
Shares held following the reported transactions include 8,220 restricted stock units, which are subject to forfeiture until they vest.
Footnote F3
Shares include 327 shares acquired under the Issuer's Employee Stock Purchase Plan on May 17, 2021.
Footnote F4
The shares were sold in multiple transactions at prices ranging from $101.055 to $101.061, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
Footnote F5
This option was granted for a total of 4,800 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vested on the first anniversary of December 21, 2012, the vesting commencement date, and the balance of the shares vested in equal monthly installments over the next 36 months thereafter.